Total Liabilities Summary of PharmaEngine, Inc.

PharmaEngine, Inc.'s latest annual total liabilities in 2023 was 91 Million TWD , down -3.66% from previous year.
PharmaEngine, Inc.'s latest quarterly total liabilities in 2024 Q2 was 327.68 Million TWD , up 178.72% from previous quarter.
PharmaEngine, Inc. reported annual total liabilities of 94.46 Million TWD in 2022, up 7.71% from previous year.
PharmaEngine, Inc. reported annual total liabilities of 87.7 Million TWD in 2021, down -55.2% from previous year.
PharmaEngine, Inc. reported quarterly total liabilities of 117.56 Million TWD for 2024 Q1, up 29.18% from previous quarter.
PharmaEngine, Inc. reported quarterly total liabilities of 95.53 Million TWD for 2023 Q1, up 1.13% from previous quarter.

Annual Total Liabilities Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Total Liabilities of PharmaEngine, Inc. (2023 - 2009)

Year	Total Liabilities	Total Liabilities Growth
2023	91 Million TWD	-3.66%
2022	94.46 Million TWD	7.71%
2021	87.7 Million TWD	-55.2%
2020	195.77 Million TWD	22.06%
2019	160.39 Million TWD	5.06%
2018	152.67 Million TWD	-23.63%
2017	199.89 Million TWD	24.56%
2016	160.48 Million TWD	102.09%
2015	79.41 Million TWD	340.73%
2014	18.01 Million TWD	-30.44%
2013	25.9 Million TWD	82.39%
2012	14.2 Million TWD	-8.9%
2011	15.59 Million TWD	12.6%
2010	13.84 Million TWD	-54.6%
2009	30.49 Million TWD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	327.68 Million TWD	178.72%
2024 Q1	117.56 Million TWD	29.18%
2023 Q1	95.53 Million TWD	1.13%
2023 Q3	74.77 Million TWD	-82.78%
2023 Q4	91 Million TWD	21.7%
2023 FY	91 Million TWD	-3.66%
2023 Q2	434.24 Million TWD	354.53%
2022 Q1	80.23 Million TWD	-8.52%
2022 Q3	100.08 Million TWD	-79.08%
2022 Q4	94.46 Million TWD	-5.61%
2022 FY	94.46 Million TWD	7.71%
2022 Q2	478.35 Million TWD	496.21%
2021 Q2	140.65 Million TWD	-22.49%
2021 Q3	77.73 Million TWD	-44.73%
2021 Q4	87.7 Million TWD	12.83%
2021 Q1	181.46 Million TWD	-7.31%
2021 FY	87.7 Million TWD	-55.2%
2020 Q4	195.77 Million TWD	41.13%
2020 Q3	138.72 Million TWD	-39.07%
2020 FY	195.77 Million TWD	22.06%
2020 Q1	147.6 Million TWD	-7.98%
2020 Q2	227.69 Million TWD	54.26%
2019 Q3	166.89 Million TWD	-44.18%
2019 Q4	160.39 Million TWD	-3.89%
2019 FY	160.39 Million TWD	5.06%
2019 Q1	144.79 Million TWD	-5.16%
2019 Q2	299 Million TWD	106.51%
2018 Q1	186.47 Million TWD	-6.72%
2018 Q4	152.67 Million TWD	224.69%
2018 Q3	47.02 Million TWD	-86.63%
2018 Q2	351.62 Million TWD	88.56%
2018 FY	152.67 Million TWD	-23.63%
2017 Q1	141.54 Million TWD	-11.8%
2017 Q4	199.89 Million TWD	331.26%
2017 Q3	46.35 Million TWD	-87.82%
2017 Q2	380.64 Million TWD	168.93%
2017 FY	199.89 Million TWD	24.56%
2016 Q3	21.56 Million TWD	-91.94%
2016 FY	160.48 Million TWD	102.09%
2016 Q2	267.68 Million TWD	313.13%
2016 Q1	64.79 Million TWD	-18.41%
2016 Q4	160.48 Million TWD	644.22%
2015 Q3	43.7 Million TWD	-69.55%
2015 Q4	79.41 Million TWD	81.7%
2015 Q2	143.54 Million TWD	810.22%
2015 Q1	15.77 Million TWD	-12.48%
2015 FY	79.41 Million TWD	340.73%
2014 Q3	18.25 Million TWD	23.54%
2014 Q2	14.77 Million TWD	91.75%
2014 Q1	7.7 Million TWD	-70.25%
2014 FY	18.01 Million TWD	-30.44%
2014 Q4	18.01 Million TWD	-1.28%
2013 Q2	12.38 Million TWD	82.95%
2013 Q4	25.9 Million TWD	113.46%
2013 Q3	12.13 Million TWD	-2.01%
2013 Q1	6.76 Million TWD	-52.34%
2013 FY	25.9 Million TWD	82.39%
2012 FY	14.2 Million TWD	-8.9%
2012 Q2	13.78 Million TWD	18.65%
2012 Q3	17.41 Million TWD	26.33%
2012 Q1	11.61 Million TWD	-25.48%
2012 Q4	14.2 Million TWD	-18.45%
2011 Q4	15.59 Million TWD	0.0%
2011 FY	15.59 Million TWD	12.6%
2010 FY	13.84 Million TWD	-54.6%
2009 FY	30.49 Million TWD	0.0%

Peer Total Liabilities Comparison of PharmaEngine, Inc.

Name	Total Liabilities	Total Liabilities Difference
Anti-Microbial Savior BioteQ Co., Ltd	6.99 Million TWD	-1201.201%
SYN-TECH Chem. & Pharm. Co., Ltd.	583.48 Million TWD	84.403%
Level Biotechnology Inc.	273.2 Million TWD	66.689%
Sagittarius Life Science Corp	137.82 Million TWD	33.969%
NeoCore Technology Co., Ltd.	197.47 Million TWD	53.914%
TaiMed Biologics Inc.	1.32 Billion TWD	93.146%
GlycoNex Incorporation	276.39 Million TWD	67.074%
VBI	21.25 Million TWD	-328.243%
GeneReach Biotechnology Corp.	313.7 Million TWD	70.99%
Taiwan Advance Bio-Pharmaceutical Inc.	514.65 Million TWD	82.317%
SynCore Biotechnology Co.,Ltd	21.22 Million TWD	-328.748%
Genomics BioSci & Tech. Co.,Ltd.	368.33 Million TWD	75.292%
Visgeneer Inc.	185.6 Million TWD	50.968%
Mycenax Biotech Inc.	1.32 Billion TWD	93.122%
Sunmax Biotechnology Co., Ltd.	732.98 Million TWD	87.584%
G&E Herbal Biotechnology Co., Ltd.	119.86 Million TWD	24.073%
Neith Corporation	17.43 Million TWD	-422.033%
Medigen Vaccine Biologics Corporation	2.24 Billion TWD	95.948%
TaiwanJ Pharmaceuticals Co., Ltd.	6.61 Million TWD	-1275.128%
Enimmune corporation	173.46 Million TWD	47.536%
TaiRx, Inc.	60.62 Million TWD	-50.113%
CHO Pharma, Inc.	110.83 Million TWD	17.888%
EirGenix Inc.	1.14 Billion TWD	92.053%
BioLASCO Taiwan Co., Ltd.	111.98 Million TWD	18.731%
Sunny Pharmtech Inc.	512.43 Million TWD	82.241%
Lin BioScience, Inc.	167.73 Million TWD	45.743%
BioGend Therapeutics Co., Ltd.	93.71 Million TWD	2.89%
Feng Chi Biotech Corp.	63.03 Million TWD	-44.376%
Bio Preventive Medicine Corp.	124.72 Million TWD	27.037%
Lukas Biomedical Inc.	161.05 Million TWD	43.495%
RBC Bioscience Corporation	513.08 Million TWD	82.263%
BiOptic Inc.	170.56 Million TWD	46.644%
BRIM Biotechnology, Inc.	42.15 Million TWD	-115.869%
Shine-On BioMedical Co.,Ltd.	23.25 Million TWD	-291.339%
Great Novel Therapeutics Biotech & Medicals	26.81 Million TWD	-239.41%
Syngen Biotech Co.,Ltd.	974.63 Million TWD	90.663%
Advagene Biopharma Co., Ltd.	7.97 Million TWD	-1041.57%
NaviFUS Corp.	53.4 Million TWD	-70.42%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	481.48 Million TWD	81.099%
Sinew Pharma Inc.	39.71 Million TWD	-129.153%
Andros Pharmaceuticals Co.,Ltd	58.03 Million TWD	-56.801%
Greenyn Biotechnology Co., Ltd	364.47 Million TWD	75.031%
Lumosa Therapeutics Co., Ltd.	227.69 Million TWD	60.031%
AP Biosciences Inc	106.65 Million TWD	14.669%
Medigen Biotechnology Corp.	3.53 Billion TWD	97.422%
3D Global Biotech Inc.	30.68 Million TWD	-196.62%
Pharmosa Biopharm Inc.	195.99 Million TWD	53.566%
Intech Biopharm Corporation	1.54 Billion TWD	94.103%
Oneness Biotech Co., Ltd.	866.42 Million TWD	89.496%
Eusol Biotech Co.,Ltd.	9.27 Million TWD	-881.091%
TWi Biotechnology, Inc.	55.81 Million TWD	-63.055%
Ever Supreme Bio Technology Co., Ltd	232.95 Million TWD	60.935%
TCI GENE Inc.	155.54 Million TWD	41.493%
MegaPro Biomedical Co., Ltd	25.5 Million TWD	-256.774%
Senhwa Biosciences, Inc.	46.17 Million TWD	-97.089%
Taiwan Bio Therapeutics Co., Ltd	328.47 Million TWD	72.294%
NatureWise Biotech & Medicals Corporation	64.88 Million TWD	-40.253%
Savior Lifetec Corporation	457.95 Million TWD	80.128%
TaiGen Biopharmaceuticals Holdings Limited	110.94 Million TWD	17.968%
OBI Pharma, Inc.	650.44 Million TWD	86.009%
Meribank Biotech Co., Ltd	390.81 Million TWD	76.714%
Acepodia, Inc.	384.47 Million TWD	76.33%
Caliway Biopharmaceuticals Co., Ltd.	85.55 Million TWD	-6.374%

Global Stocks Search

PharmaEngine, Inc. (4162.TWO)

Total Liabilities Summary of PharmaEngine, Inc.

Annual Total Liabilities Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Total Liabilities of PharmaEngine, Inc. (2023 - 2009)

Peer Total Liabilities Comparison of PharmaEngine, Inc.